CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Probe Breath Biopsy Test to differentiate between individuals with lung cancer and relevant contrast groups.The contrast groups wil...
Phase 2
Budapest, Hungary and 8 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Budapest, Hungary and 83 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Budapest, Hungary and 205 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Szekesfehervar, Hungary and 139 other locations
to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...
Phase 3
Budapest, Hungary and 155 other locations
docetaxel in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and unresectable NSCLC after chemoradiothera...
Phase 1
Budapest, Hungary and 33 other locations
study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Budapest, Hungary and 198 other locations
, early-stage non-small cell lung cancer....
Phase 2
Törökbálint, Hungary and 94 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...
Phase 2
Budapest, Hungary and 137 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Budapest, Hungary and 230 other locations
Clinical trials
Research sites
Resources
Legal